Misato Ito Selected Research

AS2553627

1/2018	Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
2/2017	AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Misato Ito Research Topics

Disease

10	Neoplasms (Cancer) 09/2022 - 06/2020
5	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 11/2020
2	Neoplasm Metastasis (Metastasis) 09/2022 - 08/2021
2	Anemia 06/2022 - 02/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
2	Rheumatoid Arthritis 10/2018 - 01/2017
2	Fibrosis (Cirrhosis) 01/2018 - 02/2017
1	Bites and Stings (Sting) 11/2022
1	Melanoma (Melanoma, Malignant) 09/2022
1	Hemorrhage 06/2022
1	Polyps 06/2022
1	Upper Extremity Deep Vein Thrombosis 03/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Adenoma (Adenomas) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Essential Hypertension 10/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2021
1	Esophageal Neoplasms (Esophageal Cancer) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2018
1	Infections 05/2018
1	Atrophy 01/2018
1	Inflammation (Inflammations) 01/2018
1	Arthritis (Polyarthritis) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2009
1	Stroke (Strokes) 05/2009
1	Brain Injuries (Brain Injury) 05/2009
1	Alzheimer Disease (Alzheimer's Disease) 05/2009
1	Multiple Sclerosis 05/2009

Drug/Important Bio-Agent (IBA)

3	Calcibiotic Root Canal SealerIBA 11/2022 - 11/2020
3	Janus Kinase InhibitorsIBA 01/2018 - 01/2017
2	Chemotactic FactorsIBA 11/2022 - 01/2021
2	LigandsIBA 09/2022 - 10/2021
2	Tn antigenIBA 10/2021 - 11/2020
2	ChemokinesIBA 01/2021 - 05/2009
2	Phosphotransferases (Kinase)IBA 05/2018 - 02/2017
2	AS2553627IBA 01/2018 - 02/2017
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2022
1	InterferonsIBA 11/2022
1	Carcinoembryonic AntigenIBA 09/2022
1	Immunoglobulins (Immunoglobulin)IBA 09/2022
1	IronIBA 06/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	CarbohydratesIBA 10/2021
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 10/2021
1	AntigensIBA 10/2021
1	Immune Checkpoint ProteinsIBA 10/2021
1	DiureticsIBA 10/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Polysaccharides (Glycans)IBA 11/2020
1	AutoantibodiesIBA 10/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2018
1	Janus KinasesIBA 10/2018
1	LipidsIBA 05/2018
1	AntibodiesIBA 05/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2017
1	Erythropoietin FDA Link 02/2017
1	CytokinesIBA 02/2017
1	peficitinibIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2009

Therapy/Procedure

3	Immunotherapy 09/2022 - 08/2021
3	Esophagectomy 03/2022 - 12/2020
1	Therapeutics 09/2022
1	Central Venous Catheters 03/2022
1	Drug Therapy (Chemotherapy) 08/2021
1	Drug Prescriptions 03/2021
1	Renal Dialysis (Hemodialysis) 02/2021
1	Proctectomy 06/2020
1	Gastrectomy 01/2020
1	Transplantation 02/2017